throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL
`BOARD
`
`SANDOZ INC.,
`Petitioner
`
`v.
`
`ABBVIE BIOTECHNOLOGY LTD.,
`Patent Owner
`
`U.S. Patent No.: 8,911,737
`Issue Date: Dec. 16, 2014
`Title: Methods of Administering Anti-TNFa Antibodies
`
`DECLARATION OF VICTORIA L. REINES
`
`

`

`DECLARATION OF VICTORIA L. REINES
`
`I, Victoria L. Reines declare that:
`
`1.
`
`I am an associate at the law firm Arnold & Porter Kaye Scholer LLP,
`
`250 West 55th St., New York, NY 10019, which represents Petitioner Sandoz Inc.
`
`in the above matter. I make the following statements based on personal
`
`knowledge.
`
`2.
`
`The table below identifies the true and correct copies of exhibits
`
`submitted along with this declaration.
`
`Description
`
`Exhibit
`No.
`1018 Remicadew (infliximab) 1998 label (Aug. 1998)
`United States Patent No. 9,017,680, filed Nov. 14, 2014, issued
`Apr. 28, 2015
`Luke Timmerman, Abbott's Humira, the 3rd-in-Class Drug That
`Toppled Lipitor as No. 1, XCONOMY (Apr. 16, 2012), available at
`http://wvvvv.xconomy.com/nationa1/2012/04/16/abbotts-humira-
`the-3rd-in-class-drug-that-toppled-lipitor-as-no-1/#
`Amgen Inc. v. AbbVie Biotech. Ltd., No. IPR2015-01517 (Patent
`Owner's Preliminary Response, Oct. 19, 2015)
`United States Patent No. 9,090,689, filed Apr. 8, 2015, issued
`July 28, 2015
`Coherus BioSciences Inc. v. AbbVie Biotechnology Ltd., No.
`IPR2016-00172, Patent Owner's Updated Exhibit List (as of
`January 19, 2017) (January 19, 2017)
`United States Patent No. 9,073,987, filed May 30, 2014, issued
`July 7, 2015
`Coherus BioSciences Inc. v. AbbVie Biotechnology Ltd., No.
`IPR2016-00172, Patent Owner's Response (Sept. 13, 2016)
`
`1021
`
`1031
`
`1035
`
`1049
`
`1069
`
`1098
`
`1105
`
`64199436
`
`

`

`3.
`
`I ordered a copy of N. Swartz, The Treatment of 124 Cases of
`
`Ulcerative Colitis With Salazopyrin and Attempts of Destabilisation in Cases of
`
`Hypersensitives to Sulfa, 130 AcTA MED. ScAND. 465 (1948) from the Arnold &
`
`Porter Kaye Scholer LLP Library, and they obtained a copy of the article with a
`
`cover sheet (Exhibit 1033) from WTS. Exhibit 1033 states that the article was
`
`published in 1948.
`
`4.
`
`According to Amazon's database, the 2001 Physician's Desk
`
`Reference (55th ed.) was published in November 2000, excerpts of which are
`
`attached to the Declarations as exhibits 1007 and 1051. Exhibit 1048 is a true and
`
`correct printout from Amazon at the following URL which demonstrates this
`
`publication date: https://www.amazon.com/Physicians-Desk-Reference-2001-
`
`Pdr/dp/1563633752.
`
`5. As shown in Exhibit 1071, the website for the journal
`
`Gastroenterology indicates that Feagan II (ex. 1099) was published in
`
`Gastroenterology, volume 118 in April 2000, available at
`
`http://vvww.gastrojournal.org/article/S0016-5085(00)84761-7/abstract.
`
`6. At my direction, library personnel at the New York Academy of
`
`Medicine obtained copies of the following references:
`
`2
`
`64199436
`
`

`

`1004
`
`Description
`Ex. No.
`1003 B. A. van de Putte et al., Efficacy of the Fully Human Anti-TNF
`Antibody D2E7 in Rheumatoid Arthritis, 42 ARTHRITIS & RHEUMATISM
`(1999) (ACR Abstract Concurrent Session, RA: TNF Blockade, Wed.,
`Nov. 17, 1999 5400)
`Joachim Kempeni, Preliminary Results of Early Clinical Trials with the
`Fully Human Anti-TNFa Monoclonal Antibody D2E7, 58 ANNALS
`RHEUMATIC DISEASES 170 (1999)
`1022 Hendrik M. van Dullemen et al., Treatment of Therapy-Resistant
`Perineal Metastatic Crohn's Disease After Proctectomy Using Anti-
`Tumor Necrosis Factor Chimeric Monoclonal Antibody, cA2, 41
`DISEASES COLON & RECTUM 98 (1998)
`1023 William J. Sandborn et al., An Engineered Human Antibody to TNF
`(CDP571) for Active Crohn's Disease: A Randomized Double-Blind
`Placebo-Controlled Trial, 120 GASTROENTEROLOGY 1330 (May 2001)
`TEXTBOOK OF RHEUMATOLOGY vol. 1 (William N. Kelley et al. eds.,
`4th ed. 1993)
`1099 Brian G. Feagan et al., A Randomized, Double-Blind, Placebo-
`Controlled, Multi-Center Trial of the Engineered Human Antibody to
`TNF (CDP571) for Steroid Sparing and Maintenance of Remission in
`Patients with Steroid-Dependent Crohn's Disease, 118
`GASTROENTEROLOGY A655 (April 2000)
`1103 Hendrik M. Van Dullemen et al., Treatment of Crohn's Disease with
`Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2), 109
`GASTROENTEROLOGY 129 (1995)
`
`1029
`
`7. (cid:9)
`
`At my direction, Independence Legal Support and the Arnold &
`
`Porter Kaye Scholer Library obtained copies of the following exhibits from the
`
`following libraries:
`
`Description
`
`Exhibit
`No.
`1005 William J. Sandborn & Stephen B. Hanauer,
`Antitumor Necrosis Factor Therapy for
`Inflammatory Bowel Disease: A Review of Agents,
`Pharmacology, Clinical Results, and Safety, 5
`
`Library
`
`National Library
`of Medicine
`
`3
`
`64199436
`
`

`

`Exhibit
`No.
`
`Description
`
`1007
`
`1025
`
`1026
`
`INFLAMMATORY BOWEL DISEASES 119 (1999)
`2001 PHYSICIAN'S DESK REFERENCE (55th ed.,
`published Nov. 2000) (excerpts)
`1016 Douglas J. Perkins et al., Reduction of NOS2
`Overexpression in Rheumatoid Arthritis Patients
`Treated with Anti-Tumor Necrosis Factor a
`Monoclonal Antibody (cA2), 41 ARTHRITIS &
`RHEUMATISM 2205 (1998)
`E. C. C. Rankin et al., The Therapeutic Effects of
`an Engineered Human Anti-Tumour Necrosis
`Factor Alpha Antibody (CDP571) in Rheumatoid
`Arthritis, 34 BRIT. J. RHEUMATOLOGY 334 (1995)
`Ernest H.S. Choy et al., The Engineered Human
`Anti-Tumor Necrosis Factor-a Antibody CDP571
`Inhibits Inflammatory Pathways But Not T Cell
`Activation in Patients with Rheumatoid Arthritis,
`26 J. RHEUMATOLOGY 2310 (1999)
`SLEISENGER & FORDTRAN'S GASTROINTESTINAL
`AND LIVER DISEASE: PATHOPHYSIOLOGY,
`DIAGNOSIS, MANAGEMENT vol. 2 (Mark Feldman et
`al. eds., 6th ed. 1998)
`1032 Ute Kettritz et al., Crohn's Disease: Pilot Study
`Comparing MRI of the Abdomen with Clinical
`Evaluation, 21 J. CLINICAL GASTROENTEROLOGY
`249 (1995)
`1034 K. Eberhardt & E. Fex, Clinical Course and
`Remission Rate in Patients with Early Rheumatoid
`Arthritis: Relationship to Outcome After 5 Years,
`37 BRIT. J. RHEUMATOLOGY 1324 (1998)
`1036 A. M. Denman, Rheumatoid Arthritis: Aetiology, 4
`BRIT. MED. J. 601 (1970)
`Rodrick J. Chiodini et al., Possible Role of
`Mycobacteria in Inflammatory Bowel Disease: I.
`An Unclassified Mycobacterium Species Isolated
`from Patients with Crohn's Disease, 29 DIGESTIVE
`DISEASES & SCI. 1073 (1984)
`1038 W. E. W. Roediger, A New Hypothesis for the
`
`1027
`
`1037
`
`4
`
`Library
`
`Arnold & Porter
`Library
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`Library of
`Congress
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`Library of
`Congress
`
`National Library
`
`64199436
`
`

`

`Exhibit
`No.
`
`Description
`
`1039
`
`1040
`
`1045
`
`1047
`
`Aetiology of Crohn's Disease—Evidence from Lipid
`Metabolism and Intestinal Tuberculosis, 67
`POSTGRADUATE MED. J. 666 (1991)
`Robert W. Chandler et al., Serological
`Investigations for Evidence of an Infectious
`Aetiology of Rheumatoid Arthritis, 30 ANNALS
`RHEUMATIC DISEASES 274 (1971)
`Joel B. Baseman & Joseph G. Tully, Mycoplasmas:
`Sophisticated, Reemerging, and Burdened by Their
`Notoriety, 3 EMERGING INFECTIOUS DISEASES 21
`(1997)
`1043 Michael T. Collins et al., Results of Multiple
`Diagnostic Tests for Mycobacterium avium subsp.
`paratuberculosis in Patients with Inflammatory
`Bowel Disease and in Controls, 38 J. CLINICAL
`MICROBIOLOGY 4373 (Dec. 2000)
`R. G. White & J. Gordon, Adjuvant-Activity of
`Diphtheroid' Organisms Isolated from the Joints
`of Cases of Rheumatoid Arthritis, 7 CLINICAL &
`EXPERIMENTAL IMMUNOLOGY 139 (1970)
`Pieter C. M. Res et al., Synovial Fluid T Cell
`Reactivity Against 65 kD Heat Shock Protein of
`Mycobacteria in Early Chronic Arthritis, 2 LANCET
`478 (1988)
`(Infliximab) Package Insert, 2001
`Remicade (cid:9)
`Physician's Desk Reference (Centocor, Inc. 1999)
`Stephan R. Targan et al., A Short-Term Study of
`Chimeric Monoclonal Antibody cA2 to Tumor
`Necrosis Factor a For Crohn's Disease, 337 NEW
`ENG. J. MED. 1029 (1997)
`T. T. MacDonald et al., Tumour Necrosis Factor-
`Alpha and Interferon-Gamma Production
`Measured at the Single Cell Level in Normal and
`Inflamed Human Intestine, 81 CLINICAL &
`EXPERIMENTAL IMMUNOLOGY 301 (1990)
`1054 Nick Di Girolamo et al., Expression of TNF-a by
`Human Plasma Cells in Chronic Inflammation, 61
`
`1051
`
`1052
`
`1053
`
`Library
`
`of Medicine
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`Library of
`Congress
`
`Library of
`Congress
`
`Library of
`Congress
`
`Arnold & Porter
`Library
`Library of
`Congress
`
`Library of
`Congress
`
`Library of
`Congress
`
`5
`
`64199436
`
`

`

`Exhibit
`No.
`
`Description
`
`J. LEUKOCYTE BIOLOGY 667 (1997)
`1055 George Kollias et al., The Function of Tumour
`Necrosis Factor and Receptors in Models of Multi-
`Organ Inflammation, Rheumatoid Arthritis,
`Multiple Sclerosis and Inflammatory Bowel
`Disease, 58 ANNALS RHEUMATIC DISEASES 132
`(1999)
`1056 A. Glennas et al., Auranofin Is Safe and Superior to
`Placebo in Elderly-Onset Rheumatoid Arthritis, 36
`BRIT. J. RHEUMATOLOGY 870 (1997)
`1059 N. Svartz, The Treatment of 124 Cases of
`Ulcerative Colitis with Salazopyrine and Attempts
`of Desensibilization in Cases of Hypersensitiveness
`to Sulfa, 130 ACTA MEDICA SCANDINAVICA 465
`(1948)
`1060 A. P. Dick et al., Controlled Trial of
`Sulphasalazine in the Treatment of Ulcerative
`Colitis, 5 GUT 437 (1964)
`J. Hayllar & I. Bjarnason, Sulphasalazine in
`Ulcerative Colitis: In Memoriam?, 32 GUT 462
`(1991)
`1062 Maarten Boers et al., Randomised Comparison of
`Combined Step-Down Prednisolone, Methotrexate
`and Sulphasalazine with Sulphasalazine Alone in
`Early Rheumatoid Arthritis, 350 LANCET 309
`(1997)
`1064 D. S. Rampton & G. E. Sladen, Prostaglandin
`Synthesis Inhibitors in Ulcerative Colitis:
`Flurbiprofen Compared with Conventional
`Treatment, 21 PROSTAGLANDINS 417 (1981)
`1065 D. S. Rampton & G. E. Sladen, Relationship
`Between Rectal Mucosal Prostaglandin Production
`and Water and Electrolyte Transport in Ulcerative
`Colitis, 30 DIGESTION 13 (1984)
`Christian Moens & J. Brocteur, Treatment of
`Rheumatoid Arthritis with Immunosuppresive
`Drugs ,1 1 ACTA RHEUMATOLOGICA SCANDINAVICA
`
`1068
`
`1061
`
`Library
`
`University of
`Washington
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`Library of
`Congress
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`6
`
`64199436
`
`

`

`Exhibit
`No.
`
`Description
`
`1070
`
`1072
`
`212 (1961)
`S. Candy et al., A Controlled Double Blind Study of
`Azathioprine in the Management of Crohn's
`Disease, 37 GUT 674 (1995)
`J. Woodland et al., Azathioprine in Rheumatoid
`Arthritis: Double-Blind Study of Full Versus Half
`Doses Versus Placebo, 40 ANNALS RHEUMATIC
`DISEASES 355 (1981)
`1073 Knut Joachim Berg et al., Side Effects of
`Cyclosporin A Treatment in Patients with
`Rheumatoid Arthritis, 29 KIDNEY INT'L 1180
`(1986)
`1074 A.W.A.M. van Rijthoven et al., Cyclosporin
`Treatment for Rheumatoid Arthritis: A Placebo
`Controlled, Double Blind, Multicentre Study, 45
`ANNALS RHEUMATIC DISEASES 726 (1986)
`E. C. Huskisson et al., Trial Comparing D-
`Penicillamine and Gold in Rheumatoid Arthritis,
`33 ANNALS RHEUMATIC DISEASES 532 (1974)
`1083 M. Lemann et al., Methotrexate for the Treatment
`of Refractory Crohn's Disease, 10 ALIMENT
`PHARMACOLOGY & THERAPIES 309 (1996)
`E. C. Huskisson et al., Immunostimulant Therapy
`with Levamisole for Rheumatoid Arthritis, 1
`LANCET 393 (1976)
`Bruce Miller et al., Double-Blind Placebo
`Controlled Crossover Evaluation of Levamisole in
`Rheumatoid Arthritis, 23 ARTHRITIS &
`RHEUMATISM 172 (1980)
`P. Franchimont et al., Double-Blind Placebo-
`Controlled Evaluation of Levamisole in Chronic
`Rheumatoid Arthritis, 8 SCANDINAVIAN J.
`RHEUMATOLOGY 43 (1979)
`1089 A. W. Segal et al., Levamisole in the Treatment of
`Crohn's Disease, 2 LANCET 382 (1977)
`Susan V. Onrust & Harriet M. Lamb, Infliximab: A
`Review of its Use in Crohn's Disease and
`
`1080
`
`1086
`
`1087
`
`1088
`
`1090
`
`Library
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`Library of
`Congress
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`Library of
`Congress
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`Library of
`Congress
`National Library
`of Medicine
`
`7
`
`64199436
`
`

`

`Exhibit
`No .
`
`Description
`
`1094
`
`1106
`
`Rheumatoid Arthritis, 10 BioDRuGs 397 (1998)
`1091 Kevin J. Tracey et al., Shock and Tissue Injury
`Induced by Recombinant Human Cachectin, 234
`Sci. 470 (1986)
`1092 Xiao-ming Sun & Wei Hsueh, Bowel Necrosis
`Induced by Tumor Necrosis Factor in Rats Is
`Mediated by Platelet-Activating Factor, 81 J.
`CLINICAL INVESTIGATION 1328 (1988)
`GOODMAN & GILMAN'S THE PHARMACOLOGICAL
`BASIS OF THERAPEUTICS (Joel G. Hardman et al.,
`eds., 9th ed. 1996)
`1095 Ann Gardulf et al., Subcutaneous Immunoglobulin
`Replacement in Patients with Primary Antibody
`Deficiencies: Safety and Costs, 345 LANCET 365
`(1995)
`1100 A. M. van Gestel et al., Development and
`Validation of the European League Against
`Rheumatism Response Criteria for Rheumatoid
`Arthritis, 39 ARTHRITIS & RHEUMATISM 34 (1996)
`R. Munro & H. Capell, Prevalence of Low Body
`Mass in Rheumatoid Arthritis: Association with the
`Acute Phase Response, 56 ANNALS RHEUMATIC
`DISEASES 326 (1997)
`1108 Michael Weisman et al., A Dose Escalation Study
`Designed to Demonstrate the Safety, Tolerability
`and Efficacy of the Fully Human Anti-TNF
`Antibody, D2E7, Given in Combination with
`Methotrexate (MTX) in Patients with Active RA, 43
`ARTHRITIS & RHEUMATISM 5391 (Sept. 2000)
`(supplement)
`R. Rau et al., Long-Term Treatment with the Fully
`Human Anti-TNF-Antibody D2E7 Slows
`Radiographic Disease Progression in Rheumatoid
`Arthritis, 42 ARTHRITIS & RHEUMATISM 5400
`(1999)
`
`1109
`
`Library
`
`Library of
`Congress
`
`Library of
`Congress
`
`Arnold & Porter
`Library
`
`Library of
`Congress
`
`National Library
`of Medicine
`
`National Library
`of Medicine
`
`University of
`Washington
`
`National Library
`of Medicine
`
`8
`
`64199436
`
`

`

`I further declare that all statements made herein of my own knowledge are
`
`true, that all statements made on information and belief are believed to be true, and
`
`that these statements were made with the knowledge that willful false statements
`
`and the like so made are punishable by fine or imprisonment, or both, under
`
`section 1001 of Title 18 of the United States Code.
`
`Dated: August 18, 2017
`
`New York, New York (cid:9)
`
`Victoria L. Reine
`
`9
`
`64199436
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket